Ronnie Guillet
Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Evoked Potentials, Auditory, Brain Stem | 6 | 1999 | 21 |
Why?
| Seizures | 7 | 1995 | 79 |
Why?
| Infant, Newborn | 34 | 1987 | 389 |
Why?
| Infant, Premature | 14 | 1987 | 70 |
Why?
| Histamine H2 Antagonists | 3 | 2006 | 7 |
Why?
| Enterocolitis, Necrotizing | 3 | 2006 | 9 |
Why?
| Caffeine | 7 | 1990 | 24 |
Why?
| Developmental Disabilities | 6 | 2000 | 54 |
Why?
| Phenobarbital | 3 | 2000 | 19 |
Why?
| Anticonvulsants | 4 | 1998 | 61 |
Why?
| Infant, Newborn, Diseases | 4 | 1995 | 33 |
Why?
| Infant, Premature, Diseases | 3 | 1997 | 37 |
Why?
| Brain Stem | 3 | 1999 | 50 |
Why?
| Betamethasone | 2 | 2003 | 9 |
Why?
| Glucocorticoids | 3 | 2000 | 107 |
Why?
| Infant, Extremely Low Birth Weight | 3 | 2007 | 7 |
Why?
| Gestational Age | 11 | 1998 | 114 |
Why?
| Kernicterus | 2 | 2001 | 3 |
Why?
| Walking | 1 | 2011 | 21 |
Why?
| Movement Disorders | 1 | 2011 | 32 |
Why?
| Skull | 1 | 2011 | 48 |
Why?
| Animals, Newborn | 11 | 1976 | 175 |
Why?
| Predictive Value of Tests | 2 | 2011 | 321 |
Why?
| Brain | 8 | 1987 | 305 |
Why?
| Electroencephalography | 4 | 1998 | 88 |
Why?
| Sepsis | 3 | 2002 | 73 |
Why?
| Infant, Very Low Birth Weight | 2 | 2006 | 21 |
Why?
| Gentamicins | 2 | 2003 | 32 |
Why?
| Female | 31 | 1976 | 1643 |
Why?
| Avoidance Learning | 2 | 1997 | 14 |
Why?
| Cerebellopontine Angle | 1 | 2007 | 7 |
Why?
| Receptors, Purinergic | 3 | 1990 | 6 |
Why?
| Prenatal Care | 2 | 2003 | 35 |
Why?
| Aging | 5 | 1980 | 275 |
Why?
| Neonatal Nursing | 1 | 2006 | 6 |
Why?
| Humans | 37 | 1987 | 1856 |
Why?
| Apnea | 2 | 1998 | 15 |
Why?
| Bilirubin | 3 | 2001 | 29 |
Why?
| Pregnancy | 12 | 1976 | 455 |
Why?
| Hypoxia-Ischemia, Brain | 3 | 2005 | 7 |
Why?
| Attitude of Health Personnel | 1 | 2008 | 165 |
Why?
| Male | 25 | 1987 | 1553 |
Why?
| Fetal Organ Maturity | 2 | 2000 | 11 |
Why?
| Questionnaires | 1 | 2008 | 360 |
Why?
| Anti-Bacterial Agents | 2 | 2003 | 195 |
Why?
| Jaundice | 1 | 2002 | 8 |
Why?
| Retrospective Studies | 7 | 1997 | 653 |
Why?
| Intensive Care, Neonatal | 1 | 2002 | 12 |
Why?
| Energy Intake | 1 | 2002 | 38 |
Why?
| Antibiotic Prophylaxis | 1 | 2002 | 22 |
Why?
| Hypoglycemia | 1 | 2002 | 25 |
Why?
| Cross Infection | 1 | 2002 | 46 |
Why?
| Case-Control Studies | 4 | 1997 | 283 |
Why?
| Epilepsies, Partial | 1 | 2000 | 11 |
Why?
| Enteral Nutrition | 1 | 2000 | 20 |
Why?
| Streptococcal Infections | 1 | 2002 | 54 |
Why?
| Cohort Studies | 5 | 1997 | 332 |
Why?
| Iron | 2 | 2010 | 75 |
Why?
| Placenta | 2 | 2010 | 48 |
Why?
| Asphyxia Neonatorum | 4 | 1998 | 8 |
Why?
| Birth Weight | 4 | 2000 | 50 |
Why?
| Rats | 14 | 1976 | 530 |
Why?
| Cerebral Hemorrhage | 2 | 1988 | 45 |
Why?
| Reaction Time | 3 | 2000 | 81 |
Why?
| Hypothermia, Induced | 2 | 2005 | 16 |
Why?
| Prilocaine | 1 | 1998 | 4 |
Why?
| Circumcision, Male | 1 | 1998 | 10 |
Why?
| Receptors, Purinergic P1 | 2 | 1994 | 19 |
Why?
| Nerve Block | 1 | 1998 | 23 |
Why?
| Dextromethorphan | 1 | 1997 | 4 |
Why?
| Hypoxia, Brain | 1 | 1997 | 15 |
Why?
| Lidocaine | 1 | 1998 | 49 |
Why?
| Cerebral Palsy | 2 | 2005 | 17 |
Why?
| Anesthetics, Local | 1 | 1998 | 50 |
Why?
| Nutritional Status | 2 | 2002 | 27 |
Why?
| Central Nervous System Stimulants | 1 | 1997 | 32 |
Why?
| Phototherapy | 2 | 2002 | 13 |
Why?
| Dose-Response Relationship, Drug | 3 | 2007 | 431 |
Why?
| Lung | 1 | 2003 | 232 |
Why?
| Labetalol | 1 | 1995 | 3 |
Why?
| Eclampsia | 1 | 1995 | 8 |
Why?
| Maternal Welfare | 1 | 1995 | 10 |
Why?
| Glucagon | 1 | 1995 | 31 |
Why?
| Bronchopulmonary Dysplasia | 2 | 2000 | 24 |
Why?
| Pain | 1 | 1998 | 191 |
Why?
| Mothers | 1 | 1995 | 47 |
Why?
| Dexamethasone | 2 | 2000 | 109 |
Why?
| Pregnancy Complications, Hematologic | 2 | 2010 | 16 |
Why?
| Anemia, Iron-Deficiency | 2 | 2010 | 28 |
Why?
| Infant | 5 | 2000 | 464 |
Why?
| Incidence | 2 | 2002 | 336 |
Why?
| Prospective Studies | 5 | 1998 | 545 |
Why?
| Mentors | 1 | 2011 | 22 |
Why?
| Leadership | 1 | 2011 | 24 |
Why?
| Pregnancy Complications | 2 | 2005 | 98 |
Why?
| Prognosis | 2 | 2000 | 388 |
Why?
| Heart Failure | 1 | 1995 | 106 |
Why?
| Receptors, Virus | 1 | 2011 | 19 |
Why?
| Animals | 16 | 1974 | 1031 |
Why?
| United States | 3 | 2006 | 604 |
Why?
| Program Development | 1 | 2011 | 61 |
Why?
| Neurologic Examination | 1 | 2011 | 64 |
Why?
| Guidelines as Topic | 1 | 2011 | 77 |
Why?
| Faculty, Medical | 1 | 2011 | 45 |
Why?
| Receptors, Transferrin | 1 | 2010 | 14 |
Why?
| Pregnancy in Adolescence | 1 | 2011 | 27 |
Why?
| Heme | 1 | 2011 | 19 |
Why?
| Membrane Transport Proteins | 1 | 2011 | 43 |
Why?
| Risk Factors | 4 | 1997 | 555 |
Why?
| Locomotion | 1 | 1990 | 24 |
Why?
| Age Factors | 4 | 1991 | 480 |
Why?
| Education, Medical | 1 | 2011 | 79 |
Why?
| Longitudinal Studies | 2 | 2007 | 195 |
Why?
| Sensation Disorders | 1 | 2009 | 11 |
Why?
| Logistic Models | 3 | 1998 | 251 |
Why?
| Adrenocorticotropic Hormone | 2 | 1978 | 31 |
Why?
| Hyperbilirubinemia, Neonatal | 1 | 2008 | 5 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 1998 | 22 |
Why?
| Xylazine | 1 | 1988 | 3 |
Why?
| Reference Values | 2 | 1997 | 278 |
Why?
| Thiazines | 1 | 1988 | 8 |
Why?
| Drug Utilization | 1 | 2008 | 32 |
Why?
| Ketamine | 1 | 1988 | 12 |
Why?
| Monte Carlo Method | 1 | 2008 | 40 |
Why?
| Anesthetics | 1 | 1988 | 21 |
Why?
| Calcinosis | 1 | 1988 | 54 |
Why?
| Central Nervous System Agents | 1 | 1988 | 5 |
Why?
| Central Nervous System Depressants | 1 | 1988 | 12 |
Why?
| Corneal Diseases | 1 | 1988 | 19 |
Why?
| Survival Rate | 4 | 2000 | 250 |
Why?
| Neonatal Screening | 2 | 1997 | 19 |
Why?
| Anti-Inflammatory Agents | 1 | 2009 | 80 |
Why?
| Bayes Theorem | 2 | 2003 | 24 |
Why?
| Embryonic and Fetal Development | 1 | 1988 | 52 |
Why?
| Nervous System | 1 | 1988 | 52 |
Why?
| Epilepsy, Benign Neonatal | 1 | 2007 | 2 |
Why?
| Treatment Outcome | 5 | 1995 | 661 |
Why?
| Sensitivity and Specificity | 3 | 1997 | 427 |
Why?
| Drug Administration Schedule | 3 | 1998 | 191 |
Why?
| Survival Analysis | 2 | 1998 | 205 |
Why?
| Delivery, Obstetric | 1 | 2007 | 21 |
Why?
| Data Interpretation, Statistical | 1 | 2007 | 109 |
Why?
| Pentylenetetrazole | 2 | 1995 | 9 |
Why?
| Time Factors | 3 | 1988 | 896 |
Why?
| Respiration, Artificial | 2 | 1998 | 81 |
Why?
| National Institutes of Health (U.S.) | 1 | 2006 | 45 |
Why?
| Research Design | 1 | 2007 | 169 |
Why?
| Clinical Competence | 1 | 2008 | 130 |
Why?
| Jaundice, Neonatal | 1 | 2005 | 7 |
Why?
| Magnetic Resonance Imaging | 1 | 2011 | 294 |
Why?
| Recurrence | 1 | 2007 | 261 |
Why?
| Hippocampus | 2 | 1994 | 83 |
Why?
| Analysis of Variance | 2 | 1995 | 339 |
Why?
| Sex Factors | 2 | 1995 | 284 |
Why?
| Corticosterone | 3 | 1976 | 25 |
Why?
| Nutritional Support | 1 | 2002 | 3 |
Why?
| Monitoring, Physiologic | 2 | 1998 | 81 |
Why?
| Body Temperature | 1 | 2002 | 44 |
Why?
| Adenosine | 2 | 1991 | 57 |
Why?
| Patient Transfer | 1 | 2002 | 25 |
Why?
| Weight Gain | 1 | 2002 | 30 |
Why?
| Streptococcus agalactiae | 1 | 2002 | 12 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2002 | 18 |
Why?
| Hernia, Diaphragmatic | 1 | 2002 | 21 |
Why?
| Prenatal Diagnosis | 1 | 2002 | 31 |
Why?
| Age of Onset | 1 | 2002 | 64 |
Why?
| Linear Models | 1 | 2003 | 151 |
Why?
| Patient Discharge | 1 | 2002 | 61 |
Why?
| Cerebral Cortex | 2 | 1991 | 108 |
Why?
| Rats, Inbred Strains | 2 | 1988 | 170 |
Why?
| Corticotropin-Releasing Hormone | 2 | 1978 | 10 |
Why?
| Administration, Oral | 2 | 1990 | 170 |
Why?
| Phenylisopropyladenosine | 2 | 1990 | 4 |
Why?
| Phosphocreatine | 3 | 1987 | 11 |
Why?
| Respiratory Syncytial Virus Infections | 1 | 2003 | 35 |
Why?
| Serum Albumin | 1 | 2001 | 55 |
Why?
| Phenytoin | 1 | 2000 | 16 |
Why?
| Audiometry, Evoked Response | 1 | 2000 | 7 |
Why?
| ROC Curve | 1 | 2001 | 80 |
Why?
| Lorazepam | 1 | 2000 | 11 |
Why?
| Hospitalization | 1 | 2003 | 169 |
Why?
| Infant Food | 1 | 2000 | 13 |
Why?
| Demography | 1 | 2000 | 87 |
Why?
| Child, Preschool | 1 | 2007 | 554 |
Why?
| Blood-Brain Barrier | 1 | 2001 | 63 |
Why?
| Diazepam | 2 | 1990 | 17 |
Why?
| Lung Diseases, Obstructive | 1 | 2000 | 30 |
Why?
| Risk | 1 | 2001 | 203 |
Why?
| Pituitary Gland | 1 | 1980 | 17 |
Why?
| Adrenal Glands | 1 | 1980 | 35 |
Why?
| Hearing | 1 | 1999 | 20 |
Why?
| Milk, Human | 1 | 2000 | 23 |
Why?
| Body Weight | 2 | 1990 | 178 |
Why?
| Algorithms | 1 | 2003 | 226 |
Why?
| Follow-Up Studies | 3 | 2005 | 553 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 241 |
Why?
| Penis | 1 | 1998 | 24 |
Why?
| Anesthesia, Local | 1 | 1998 | 17 |
Why?
| New York | 1 | 2002 | 422 |
Why?
| Single-Blind Method | 1 | 1998 | 86 |
Why?
| Pituitary-Adrenal System | 1 | 1978 | 19 |
Why?
| Kinetics | 2 | 1991 | 349 |
Why?
| Child | 1 | 2007 | 749 |
Why?
| Models, Biological | 1 | 2003 | 410 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 1990 | 46 |
Why?
| Retention (Psychology) | 1 | 1997 | 7 |
Why?
| Stress, Physiological | 1 | 1978 | 76 |
Why?
| Severity of Illness Index | 2 | 2010 | 358 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 38 |
Why?
| Pain Measurement | 1 | 1998 | 98 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 1987 | 74 |
Why?
| Pulmonary Surfactants | 1 | 1998 | 35 |
Why?
| Convulsants | 1 | 1995 | 10 |
Why?
| Picrotoxin | 1 | 1995 | 7 |
Why?
| Strychnine | 1 | 1995 | 6 |
Why?
| Bicuculline | 1 | 1995 | 12 |
Why?
| Disease Susceptibility | 1 | 1995 | 61 |
Why?
| Kainic Acid | 1 | 1995 | 17 |
Why?
| Arachnida | 1 | 1974 | 1 |
Why?
| Tritium | 1 | 1994 | 65 |
Why?
| Pyramidal Cells | 1 | 1994 | 14 |
Why?
| Autoradiography | 1 | 1994 | 73 |
Why?
| Thalamus | 1 | 1994 | 23 |
Why?
| Sex Characteristics | 1 | 1995 | 85 |
Why?
| Cerebellum | 1 | 1994 | 59 |
Why?
| Organ Specificity | 1 | 1994 | 104 |
Why?
| Muscles | 1 | 1974 | 111 |
Why?
| Radioligand Assay | 1 | 1991 | 30 |
Why?
| Adolescent | 2 | 2010 | 891 |
Why?
| National Institute of Child Health and Human Development (U.S.) | 1 | 2010 | 3 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2011 | 33 |
Why?
| Ferritins | 1 | 2010 | 36 |
Why?
| Ligands | 1 | 1991 | 116 |
Why?
| Hematocrit | 1 | 2010 | 60 |
Why?
| Pregnancy Trimester, Second | 1 | 2010 | 25 |
Why?
| Hemoglobins | 1 | 2010 | 74 |
Why?
| Motor Activity | 1 | 1991 | 104 |
Why?
| Fetal Blood | 1 | 2010 | 54 |
Why?
| Organ Size | 1 | 2010 | 118 |
Why?
| Receptors, GABA-A | 1 | 1990 | 14 |
Why?
| Disability Evaluation | 1 | 2010 | 61 |
Why?
| Infant Mortality | 1 | 2008 | 22 |
Why?
| Neoplasm Proteins | 1 | 2011 | 110 |
Why?
| Yohimbine | 1 | 1988 | 10 |
Why?
| Drug Combinations | 1 | 1988 | 95 |
Why?
| Oxidative Phosphorylation | 1 | 1987 | 19 |
Why?
| Head | 1 | 1987 | 41 |
Why?
| Neurons | 1 | 1994 | 195 |
Why?
| Cornea | 1 | 1988 | 36 |
Why?
| Obstetric Labor Complications | 1 | 2005 | 15 |
Why?
| Blindness | 1 | 2005 | 22 |
Why?
| Hearing Loss | 1 | 2005 | 17 |
Why?
| Acidosis | 1 | 2005 | 29 |
Why?
| Intensive Care Units, Neonatal | 1 | 2003 | 33 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2003 | 31 |
Why?
| Primary Prevention | 1 | 2003 | 44 |
Why?
| Antiviral Agents | 1 | 2003 | 91 |
Why?
| Practice Guidelines as Topic | 1 | 2003 | 174 |
Why?
| Adult | 1 | 1995 | 1317 |
Why?
| Oxygen Inhalation Therapy | 1 | 2000 | 33 |
Why?
| Risk Assessment | 1 | 2003 | 324 |
Why?
| Length of Stay | 1 | 2000 | 166 |
Why?
| Resuscitation | 1 | 1998 | 31 |
Why?
| Ether, Ethyl | 1 | 1978 | 5 |
Why?
| Adrenal Cortex | 1 | 1978 | 11 |
Why?
| Congenital Abnormalities | 1 | 1998 | 25 |
Why?
| Pituitary Gland, Anterior | 1 | 1978 | 6 |
Why?
| Paralysis | 1 | 1998 | 37 |
Why?
| Confidence Intervals | 1 | 1998 | 104 |
Why?
| Probability | 1 | 1998 | 190 |
Why?
| Microwaves | 1 | 1976 | 15 |
Why?
| Pregnancy, Animal | 1 | 1976 | 20 |
Why?
| Extremities | 1 | 1974 | 32 |
Why?
| Axons | 1 | 1974 | 66 |
Why?
| Flumazenil | 1 | 1990 | 6 |
Why?
| Phosphorus | 1 | 1990 | 29 |
Why?
| Phosphorus Isotopes | 1 | 1988 | 9 |
Why?
| Hydrogen-Ion Concentration | 1 | 1990 | 176 |
Why?
| Posture | 1 | 1987 | 68 |
Why?
| Phosphates | 1 | 1987 | 71 |
Why?
| Cerebrovascular Circulation | 1 | 1987 | 62 |
Why?
| Adenosine Triphosphate | 1 | 1988 | 121 |
Why?
| Litter Size | 1 | 1976 | 4 |
Why?
| Thyroxine | 1 | 1976 | 26 |
Why?
| Cold Temperature | 1 | 1976 | 59 |
Why?
|
|
Guillet's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
